Can 18F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis
Objectives This study aimed to explore the diagnostic significance of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT for predicting the presence of epidermal growth factor receptor (EGFR) mutations in patients with non-small cell lung cancer (NSCLC).Design A systematic review...
Saved in:
| Main Authors: | Shu Wang, Yaming Li, Yan Cui, Xuena Li, Bulin Du, Guanghui Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/6/e044313.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Properties of S. aureus spondylodiscitis in CT and F18-FDG-PET/CT
by: J. Hockmann, et al.
Published: (2024-01-01) -
18F-FDG PET/CT findings of erythema induratum
by: KyungAh Chun, MD, PhD
Published: (2025-04-01) -
Predictive Value of Initial 18F-FDG PET/CT for Identifying EGFR and KRAS Mutations in Patients with Non-small-cell Lung Cancer
by: Ozge Vural Topuz, et al.
Published: (2024-11-01) -
The Appearances of Brain Metastases of Small Cell Lung Cancer on 18F-FDG PET/CT
by: Hasan Önner, et al.
Published: (2022-08-01) -
SSB expression is associated with metabolic parameters of 18F-FDG PET/CT in lung adenocarcinoma and can improve diagnostic efficiency
by: Zi-Yue Liu, et al.
Published: (2024-11-01)